ZYDUSLIFE

Zydus Lifesciences Ltd., formed in 1995 following the restructuring of the Zydus group and the establishment of Cadila Healthcare, is a global pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of healthcare therapies. The company operates across three main segments: generic pharmaceuticals, branded pharmaceuticals, and consumer wellness. Its product offerings include Active Pharmaceutical Ingredients (APIs), finished formulations, and therapies in oncology, cardiology, and gastrointestinal health. Zydus Lifesciences maintains extensive research and development capabilities with a vertically integrated structure spanning from APIs to finished formulations. Operating within the pharmaceuticals and healthcare industries, the company serves a global market. Since its inception, the group's turnover expanded substantially from Rs. 250 crores in 1995 to over Rs. 14,253 crores in FY20.